Published in Biochemistry on January 14, 1975
Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors. Proc Natl Acad Sci U S A (1991) 1.37
Role of purine nucleoside phosphorylase in interactions between 2',3'-dideoxyinosine and allopurinol, ganciclovir, or tenofovir. Antimicrob Agents Chemother (2004) 1.13
Metabolism of 2',3'-dideoxyinosine (ddI) in human blood. Br J Clin Pharmacol (1992) 0.95
Partial purification and properties of purine nucleoside phosphorylase from rabbit erythrocytes. Biochem J (1977) 0.90
Rabbit erythrocyte purine nucleoside phosphorylase. Initial-velocity studies. Biochem J (1979) 0.83
A canine model of induced purine nucleoside phosphorylase deficiency. Clin Exp Immunol (1986) 0.82
Purification and characterization of a novel nucleoside phosphorylase from a Klebsiella sp. and its use in the enzymatic production of adenine arabinoside. Appl Environ Microbiol (1990) 0.79
Conservation of structure and activity in Plasmodium purine nucleoside phosphorylases. BMC Struct Biol (2009) 0.79
Enhancing gold recovery from electronic waste via lixiviant metabolic engineering in Chromobacterium violaceum. Sci Rep (2013) 0.77
Purification and characterization of purine nucleoside phosphorylase from Proteus vulgaris. Appl Environ Microbiol (1990) 0.77
Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors. Biochem Pharmacol (1977) 2.13
Purine Metabolism in Tetrahymena and Its Relation to Malignant Cells in Mice. Science (1949) 1.83
Guanylate kinases from human erythrocytes, hog brain, and rat liver. Methods Enzymol (1978) 1.60
Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study. Acta Neurol Scand (2002) 1.58
Origin of the anomalous magnetic circular dichroism spectral shape in ferromagnetic Ga(1-x)MnxAs: impurity bands inside the band gap. Phys Rev Lett (2008) 1.57
Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 A resolution. J Biol Chem (1990) 1.46
Herpes zoster and post-herpetic neuralgia--a clinical trial of aspirin in chloroform for anodyne. J Assoc Physicians India (1998) 1.39
Squamous neoplasms of the stomach. Am J Roentgenol Radium Ther Nucl Med (1967) 1.36
Adenosine deaminase from human erythrocytes: purification and effects of adenosine analogs. Biochem Pharmacol (1975) 1.33
Purine nucleoside phosphorylase from human erythrocytes. IV. Crystallization and some properties. J Biol Chem (1969) 1.31
Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin. Biochem Pharmacol (1975) 1.27
Purine nucleoside phosphorylase from human erythroyctes. II. Kinetic analysis and substrate-binding studies. J Biol Chem (1968) 1.22
Purine nucleoside phosphorylase from human erythrocytes. I. Purification and properties. J Biol Chem (1968) 1.19
Human erythrocytic purine nucleoside phosphorylase: reaction with sugar-modified nucleoside substrates. Biochemistry (1980) 1.17
Nucleoside diphosphokinase from human erythrocytes. Methods Enzymol (1978) 1.17
Potent inhibition of muscle 5'-AMP deaminase by the nucleoside antibiotics coformycin and deoxycoformycin. Biochem Pharmacol (1977) 1.13
Incorporation of analog purine nucleosides into the formed elements of human blood: erythrocytes, platelets, and lymphocytes. Ann N Y Acad Sci (1975) 1.13
Drug resistance in Salmonellae isolated at Chandigarh (India) during 1972-1978. Antonie Van Leeuwenhoek (1980) 1.10
Purine nucleoside phosphorylase. 2. Catalytic mechanism. Biochemistry (1997) 1.10
Inhibitors of adenosine deaminase. Pharmacol Ther (1982) 1.09
Meningitis in a new born due to Flavobacterium meningosepticum. Indian J Med Res (1971) 1.09
Severe and complicated malaria in Bikaner (Rajasthan), western India. Southeast Asian J Trop Med Public Health (1997) 1.08
Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis. Biochemistry (1997) 1.05
Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency. J Clin Invest (1976) 1.03
Erythrocytic nucleoside diphosphokinase. II. Isolation and kinetics. J Biol Chem (1966) 1.03
Inhibitors of purine nucleoside phosphorylase, C(8) and C(5') substitutions. Biochem Pharmacol (1982) 1.03
Purine nucleoside phosphorylase from human erythrocytes. 3. Inhibition by the inosine analog formycin B of the isolated enzyme and of nucleoside metabolism in intact erythrocytes and sarcoma 180 cells. Mol Pharmacol (1968) 1.02
Decreased parotid saliva gustin/carbonic anhydrase VI secretion: an enzyme disorder manifested by gustatory and olfactory dysfunction. Am J Med Sci (1999) 1.01
Experience with Hemophilus influenzae pneumonia. Radiology (1966) 1.00
Substrate specificities of 5'-deoxy-5'-methylthioadenosine phosphorylase from Trypanosoma brucei brucei and mammalian cells. Mol Biochem Parasitol (1988) 0.98
Adenosine deaminase from human erythrocytes. Methods Enzymol (1978) 0.97
5'-Methylthioadenosine phosphorylase-L. Substrate activity of 5'-deoxyadenosine with the enzyme from Sarcoma 180 cells. Biochem Pharmacol (1981) 0.96
Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Cancer Res (1999) 0.96
Forskolin: a potential antimetastatic agent. Int J Cancer (1983) 0.95
Efficacy of exogenous oral zinc in treatment of patients with carbonic anhydrase VI deficiency. Am J Med Sci (1999) 0.95
Purine metabolism in primitive erythrocytes. Comp Biochem Physiol B (1973) 0.95
Erythrocytic nucleoside diphosphokinase. 3. Studies with free and phosphorylated enzyme and evidence for an essential thiol group. J Biol Chem (1966) 0.94
Purine nucleoside phosphorylase from human erythrocytes. Methods Enzymol (1978) 0.94
Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells. Cancer Res (1980) 0.93
Transferable drug resistance in Escherichia coli isolated from food. Indian J Med Res (1982) 0.93
Nucleotide profiles of the formed elements of human blood determined by high-pressure liquid chromatography. Blood (1973) 0.93
Clinicopathological correlates of obstructed right-sided porcine-valved extracardiac conduits. J Thorac Cardiovasc Surg (1981) 0.92
Pertussis agglutinins in vaccinated mice : difficulty in estimating the type-specific response. Indian J Med Res (1976) 0.91
Prevalence of Clostridium difficile in pseudomembranous and antibiotic-associated colitis in north India. J Diarrhoeal Dis Res (1986) 0.91
Purine nucleoside phosphorylase from human erythrocytes: physiocochemical properties of the crystalline enzyme. Biochemistry (1978) 0.90
Acute postoperative obstruction of extracardiac conduit due to separation of thin fibrous peel. Mayo Clin Proc (1982) 0.90
Shigellosis in Chandigarh. Indian J Pathol Microbiol (1977) 0.90
Nonhomogeneous labeling of liver extra-mitochondrial acetyl-CoA. Implications for the probing of lipogenic acetyl-CoA via drug acetylation and for the production of acetate by the liver. J Biol Chem (1994) 0.89
S. typhi with transferable chloramphenicol resistance isolated in Chandigarh during 1983-87. Indian J Pathol Microbiol (1994) 0.89
An hypothesis on the mechanism of action of 6-thioguanine. Biochem Pharmacol (1967) 0.89
Changes in nucleoside transport of HL-60 human promyelocytic cells during N,N-dimethylformamide induced differentiation. Cancer Res (1986) 0.88
Characterization of a defect in the pathway for converting 5'-deoxy-5'-methylthioadenosine to methionine in a subline of a cultured heterogeneous human colon carcinoma. J Biol Chem (1984) 0.88
Reaction of 5'-deoxyadenosine and related analogs with the 5'-methylthioadenosine cleaving enzyme of sarcoma 180 cells, a possible chemotherapeutic target enzyme. Biochem Pharmacol (1979) 0.87
Urinary tract infection caused by Salmonella typhimurium and S. barielly. Indian J Med Res (1982) 0.87
Incorporation of nucleosides into the nucleotide pools of human erythrocytes. Adenosine and its analogs. Biochemistry (1973) 0.87
Design of purine nucleoside phosphorylase inhibitors. Fed Proc (1986) 0.86
Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation. J Cell Biochem (1982) 0.86
Tight binding inhibitors--VIII. Studies of the interactions of 2'-deoxycoformycin and transport inhibitors with the erythrocytic nucleoside transport system. Biochem Pharmacol (1980) 0.86
Metal binding characteristics of human salivary and porcine pancreatic amylase. J Biol Chem (1987) 0.86
Clinical pharmacology of deoxycoformycin. Blood (1981) 0.85
Role of haemagglutinating Bacteroides asaccharolyticus in clinical infections. Indian J Med Res (1983) 0.85
Succinic thiokinase. V. Preparation of labeled substrates, their bindings to the enzyme, and isotope exchange studies. J Biol Chem (1967) 0.85
Co-agglutination and latex agglutination tests for the detection of Escherichia coli enterotoxin. Indian J Med Res (1981) 0.85
Assay of the human liver citric acid cycle probe phenylacetylglutamine and of phenylacetate in plasma by gas chromatography-mass spectrometry. Anal Biochem (1993) 0.84
Erythrocytic nucleoside diphosphokinase. V. Some properties and behavior of the pI 7.3 isozyme. J Biol Chem (1971) 0.83
Identification and isolation on a large scale of guanylate kinase from human erythrocytes. Effects of monophosphate nucleotides of purine analogs. Biochem Pharmacol (1971) 0.83
The interaction of the nucleoside analogues, formycins A and B, with xanthine oxidase and hepatic aldehyde oxidase. Mol Pharmacol (1970) 0.83
Rapid degradation of disulfiram by serum albumin. Res Commun Chem Pathol Pharmacol (1983) 0.83
Demonstration of the heterogeneity of nucleoside diphosphokinase in rat tissues. Biochemistry (1973) 0.82
Purine nucleoside phosphorylase from human erythrocytes. V. Content and behavior of sulfhydryl groups. J Biol Chem (1971) 0.82
Adenosine triphosphate-guanosine 5'-phosphate phosphotransferase. IV. Isozymes in human erythrocytes and Sarcoma 180 ascites cells. Mol Pharmacol (1972) 0.82
Peripheral-type benzodiazepines inhibit proliferation of astrocytes in culture. Brain Res (1991) 0.82